These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 2519903

  • 21. Synergistic effect of platelet-activating factor and tumor necrosis factor-alpha on corneal myofibroblast apoptosis.
    He J, Bazan HE.
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):883-91. PubMed ID: 16505020
    [Abstract] [Full Text] [Related]

  • 22. Regulation of inducible nitric oxide synthase messenger RNA expression and nitric oxide production by lipopolysaccharide in vivo: the roles of macrophages, endogenous IFN-gamma, and TNF receptor-1-mediated signaling.
    Salkowski CA, Detore G, McNally R, van Rooijen N, Vogel SN.
    J Immunol; 1997 Jan 15; 158(2):905-12. PubMed ID: 8993010
    [Abstract] [Full Text] [Related]

  • 23. Platelet activating factor interaction with tumor necrosis factor in myocardial ischaemia-reperfusion injury.
    Squadrito F, Ioculano M, Altavilla D, Zingarelli B, Canale P, Campo GM, Saitta A, Calapai G, Bussolino F, Caputi AP.
    J Lipid Mediat; 1993 Aug 15; 8(1):53-65. PubMed ID: 8257777
    [Abstract] [Full Text] [Related]

  • 24. Equine peritoneal macrophage production of thromboxane and prostacyclin in response to platelet activating factor and its receptor antagonist SRI 63-441.
    Morris DD, Moore JN.
    Circ Shock; 1989 Jun 15; 28(2):149-58. PubMed ID: 2544315
    [Abstract] [Full Text] [Related]

  • 25. [PAF-acether antagonistic pyrrolo[1,2-c]thiazoles: from RP 48740 to RP 59227].
    Lavé D, James C, Rajoharison H, Floch A, Robaut C, Sedivy P.
    J Pharm Belg; 1990 Jun 15; 45(3):219-23. PubMed ID: 2205718
    [Abstract] [Full Text] [Related]

  • 26. Tumor necrosis factor-alpha production induced by viruses and by lipopolysaccharides in macrophages: similarities and differences.
    Willeaume V, Kruys V, Mijatovic T, Huez G.
    J Inflamm; 1990 Jun 15; 46(1):1-12. PubMed ID: 8832967
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. An antagonist of platelet-activating factor suppresses endotoxin-induced tumor necrosis factor and mortality in mice pretreated with carrageenan.
    Ogata M, Matsumoto T, Koga K, Takenaka I, Kamochi M, Sata T, Yoshida S, Shigematsu A.
    Infect Immun; 1993 Feb 15; 61(2):699-704. PubMed ID: 8423096
    [Abstract] [Full Text] [Related]

  • 29. Platelet-activating factor and endotoxin induce tumour necrosis factor gene expression in rat intestine and liver.
    Huang L, Tan X, Crawford SE, Hsueh W.
    Immunology; 1994 Sep 15; 83(1):65-9. PubMed ID: 7821968
    [Abstract] [Full Text] [Related]

  • 30. Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor.
    Sun XM, Hsueh W.
    J Clin Invest; 1988 May 15; 81(5):1328-31. PubMed ID: 3366898
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Endotoxin-induced macrophage gene expression depends on platelet-activating factor.
    Lo CJ, Cryer HG, Fu M, Kim B.
    Arch Surg; 1997 Dec 15; 132(12):1342-7. PubMed ID: 9403541
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Modulation of pulmonary inflammation after endotoxin inhalation with a platelet-activating factor antagonist (48740 RP).
    Rylander R, Beijer L, Lantz RC, Burrell R, Sedivy P.
    Int Arch Allergy Appl Immunol; 1988 Dec 15; 86(3):303-7. PubMed ID: 3403044
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Platelet-activating factor augments tumor necrosis factor and procoagulant activity.
    Maier RV, Hahnel GB, Fletcher JR.
    J Surg Res; 1992 Mar 15; 52(3):258-64. PubMed ID: 1538603
    [Abstract] [Full Text] [Related]

  • 37. ABT-299, a novel PAF antagonist, attenuates multiple effects of endotoxemia in conscious rats.
    Albert DH, Luo G, Magoc TJ, Tapang P, Holms JH, Davidsen SK, Summers JB, Carter GW.
    Shock; 1996 Aug 15; 6(2):112-7. PubMed ID: 8856845
    [Abstract] [Full Text] [Related]

  • 38. Preventive effect of several drugs against Pseudomonas aeruginosa infection and the toxicity of combined tumor necrosis factor with lipopolysaccharide: relationship between lethality and the arachidonic cascade.
    Satomi N, Sakurai A, Iimura F, Haranaka R, Haranaka K.
    Biotherapy; 1990 Aug 15; 2(3):227-34. PubMed ID: 2169830
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. 48740 RP, an antagonist of PAF, does not affect human plasma fibrinolysis before and after venous occlusion.
    Hanss M, Dechavanne M.
    Thromb Res; 1988 Jan 01; 49(1):129-32. PubMed ID: 3126559
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.